InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Flagship Ventures Fund V General Partner LLC. Director active across 3 companies, notably Codiak BioSciences, Inc.. Cumulatively, 5 disclosures have been logged. Breakdown: 1 buy · 2 sells. Total volume traded: €3m. Activity tracked since 24 May 2023. The latest transaction was filed on 11 August 2023 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Flagship Ventures Fund V General Partner LLC is a declarant linked to Sigilon Therapeutics, Inc., Sana Biotechnology, Inc. and Codiak BioSciences, Inc. The record shows 5 filings in total. In the sampled recent filings from 2022-09-16 to 2023-08-15, the sell amount is EUR 2951142 and the most frequent transaction nature is U.